A Case of Polyglandular Autoimmune Syndrome.
- Author:
Chul Hee KIM
;
Hong Kyu KIM
;
Joong Yeol PARK
;
Young Ki SONG
;
Ki Soo KIM
;
Kyo Sang YOO
- Publication Type:Case Report
- Keywords:
Polyglandular autoimmune syndrome;
Adrenocotical insufficiency;
Autoimmune thyroiditis;
Ovarian failure
- MeSH:
Adrenocorticotropic Hormone;
Adult;
Aldosterone;
Amenorrhea;
Atrophy;
Blood Cell Count;
Blood Glucose;
Body Weight;
C-Peptide;
Chemistry;
Cicatrix;
Diabetes Mellitus, Type 1;
Endocrine System Diseases;
Estradiol;
Estrogens;
Female;
Gingiva;
Glucagon;
Hair;
Hot Temperature;
Humans;
Hydrocortisone;
Hyperthyroidism;
Mucous Membrane;
Ovary;
Physical Examination;
Pigmentation;
Progesterone;
Reference Values;
Renin;
Skin;
Sweat;
Sweating;
Thyroid Gland;
Thyroiditis, Autoimmune;
Ultrasonography
- From:Journal of Korean Society of Endocrinology
1997;12(4):672-676
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The polyglandular autoimmune syndrome is constellation of multiple endocrine insufficiencies often associated with diseases of nonendocrine organs occurring in individual patients and their families. In 1980, Neufeld classified this syndrome into three major types. Type II is characterized by adrenocortical insufficiency, autoimmune thyroiditis, and insulin-dependent diabetes mellitus. We experienced a case characterized by adrenocortical insufficiency, autoimmune thyroiditis, and ovarian failure and report with the review of the literature. A 38-year-old woman visited our clinic because of progressing brown colored pigmentation of skin and mucosa which is developed a year ago. Nine years ago prior to visit, amenorrhea was developed after right oophrectomy. Three years ago, she revealed feature of hyperthyroidism such as palpitation, loss of body weight (8kg/1-2years), heat intolerance, and sweating, so received antithyroid therapy for 14 months. Brown colored pigmentation of skin and mucosa, especially scar and gingiva, has been progressively aggravated during last year. She had no past or family history of other endocrine disease. Diffuse pigmentation of skin, loss of axillary and pubic hair, and diffuse enlargement of both thyroid glands were shown on physical examination. Blood cell count, serum chemistry and blood sugar test were all within normal range. Basal hormone levels were T3-uptake 29.7% (30~40), T3 153 ng/dL (85~185), T4 7.5ug/dL (5.5~11.5), TSH 2.4 IU (0.34~3.5), anti-TG antibody <100 U/mL (0~100), anti-microsome antibody <50 U/mL (0~100), TBII (thyrotropin binding inhibiting immunoglobulin) 2.2% ( (-15)~15), ACTH 989 pg/mL (0~37), cortisol 0.1 ug/dL (5~25), renin 7.1ng/mL/hr (1~2.5), aldosterone 81.0pg/mL (50~194), LH 115.2 mIU/mL (0.6~16.8), FSH 122 mIU/mL (1.6~19.0), and estradiol <10.0pg/mL (30~120). In ACTH stimulation test, levels of basal cortisol, 30 minutes, and 60 minutes were <0.1, <0.1, and <0.1 g/dL respectively. And, in glucagon stimulation test, levels of basal C-peptide, 5 minutes, 10 minutes, and 15 minutes were 0.9, 5,1, 6.3, and 5.5 ng/dL respectively. Thyroid scan showed diffuse enlargement of bilateral thyroid glands and pelvic ultrasonogram showed atrophy of left ovary. We administered corticosteroid, estrogen, and progesterone which were deficient to the patient, and has followed up the clinical course of the patient.
